|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global Cancer Statistics 2020:
GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36
Cancers in 185 Countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
de Freitas AC, Gurgel APAD, Chagas BS,
Coimbra EC and do Amaral CMM: Susceptibility to cervical cancer: An
overview. Gynecol Oncol. 126:304–311. 2012.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Arbyn M, Weiderpass E, Bruni L, de Sanjosé
S, Saraiya M, Ferlay J and Bray F: Estimates of incidence and
mortality of cervical cancer in 2018: A worldwide analysis. Lancet
Glob Health. 8:e191–e203. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Lei J, Ploner A, Elfström KM, Wang J, Roth
A, Fang F, Sundström K, Dillner J and Sparén P: HPV Vaccination and
the Risk of Invasive Cervical Cancer. N Engl J Med. 383:1340–1348.
2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Kessler TA: Cervical Cancer: Prevention
and Early Detection. Semin Oncol Nurs. 33:172–183. 2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Benard VB, Thomas CC, King J, Massetti GM,
Doria-Rose VP and Saraiya M: Centers for Disease Control and
Prevention (CDC). Vital signs: Cervical cancer incidence,
mortality, and screening - United States, 2007-2012. MMWR Morb
Mortal Wkly Rep. 63:1004–1009. 2014.PubMed/NCBI
|
|
7
|
Vaccarella S, Laversanne M, Ferlay J and
Bray F: Cervical cancer in Africa, Latin America and the Caribbean
and Asia: Regional inequalities and changing trends. Int J Cancer.
141:1997–2001. 2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
van Gisbergen MW, Voets AM, Starmans MHW,
de Coo IFM, Yadak R, Hoffmann RF, Boutros PC, Smeets HJM, Dubois L
and Lambin P: How do changes in the mtDNA and mitochondrial
dysfunction influence cancer and cancer therapy? Challenges,
opportunities and models. Mutat Res Rev Mutat Res. 764:16–30.
2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Kang D, Kim SH and Hamasaki N:
Mitochondrial transcription factor A (TFAM): Roles in maintenance
of mtDNA and cellular functions. Mitochondrion. 7:39–44.
2007.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Hallberg BM and Larsson N-G: TFAM forces
mtDNA to make a U-turn. Nat Struct Mol Biol. 18:1179–1181.
2011.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Gao W, Wu M-H, Wang N, Ying M-Z, Zhang
Y-Y, Hua J, Chuan L and Wang Y-J: Mitochondrial transcription
factor A contributes to cisplatin resistance in patients with
estrogen receptor positive breast cancer. Mol Med Rep.
14:5304–5310. 2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Peng H, Yang M, Chen ZY, Chen P, Guan CX,
Xiang XD, Cai S, Chen Y and Fang X: Expression and methylation of
mitochondrial transcription factor a in chronic obstructive
pulmonary disease patients with lung cancer. PLoS One.
8(e82739)2013.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Xie D, Wu X, Lan L, Shangguan F, Lin X,
Chen F, Xu S, Zhang Y, Chen Z, Huang K, et al: Downregulation of
TFAM inhibits the tumorigenesis of non-small cell lung cancer by
activating ROS-mediated JNK/p38MAPK signaling and reducing cellular
bioenergetics. Oncotarget. 7:11609–11624. 2016.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Granados JB, Méndez JP, Feria-Bernal G,
García-García E, Tejeda ME, Rojano-Mejía D, Tapia A and Canto P:
Association of a TFAM haplotype with aggressive prostate cancer in
overweight or obese Mexican Mestizo men. Urol Oncol.
35:111.e9–111.e14. 2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Guo J, Zheng L, Liu W, Wang X, Wang Z,
Wang Z, French AJ, Kang D, Chen L, Thibodeau SN, et al: Frequent
truncating mutation of TFAM induces mitochondrial DNA depletion and
apoptotic resistance in microsatellite-unstable colorectal cancer.
Cancer Res. 71:2978–2987. 2011.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Golubickaite I, Ugenskiene R,
Korobeinikova E, Gudaitiene J, Vaitiekus D, Poskiene L and
Juozaityte E: The impact of mitochondria-related POLG and TFAM
variants on breast cancer pathomorphological characteristics and
patient outcomes. Biomarkers. 26:343–353. 2021.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Hu W, Ma S-L, Liu L-L, Zhu Y-H, Zeng T-T,
Li Y and Guan X-Y: Impact of mitochondrial transcription factor A
expression on the outcomes of ovarian, endometrial and cervical
cancers. Am J Transl Res. 12:5343–5361. 2020.PubMed/NCBI
|
|
18
|
Golubickaite I, Ugenskiene R, Ziliene E,
Beniusyte J, Inciura A, Poskiene L and Juozaityte E: POLG Gene
Variants in Cervical Cancer Patients and Their Associations with
Clinical and Pathomorphological Tumor Characteristics. J Clin Med.
10(1838)2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
World Medical Association. World Medical
Association Declaration of Helsinki: Ethical principles for medical
research involving human subjects. JAMA. 310:2191–2194.
2013.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Kurman RJ, Carcangiu ML, Herrington S and
Young RH (eds): WHO Classification of Tumours of Female
Reproductive Organs. IARC, Lyon, 2014.
|
|
21
|
Kopanos C, Tsiolkas V, Kouris A, Chapple
CE, Albarca Aguilera M, Meyer R and Massouras A: VarSome: The human
genomic variant search engine. Bioinformatics. 35:1978–1980.
2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Franklin by Genoox: The Future of Genomic
Medicine. https://franklin.genoox.com/clinical-db/home. Accessed
September 25, 2021.
|
|
23
|
Grupe A, Li Y, Rowland C, Nowotny P,
Hinrichs AL, Smemo S, Kauwe JSK, Maxwell TJ, Cherny S, Doil L, et
al: A scan of chromosome 10 identifies a novel locus showing strong
association with late-onset Alzheimer disease. Am J Hum Genet.
78:78–88. 2006.PubMed/NCBI View
Article : Google Scholar
|
|
24
|
Taherzadeh-Fard E, Saft C, Akkad DA,
Wieczorek S, Haghikia A, Chan A, Epplen JT and Arning L: PGC-1alpha
downstream transcription factors NRF-1 and TFAM are genetic
modifiers of Huntington disease. Mol Neurodegener.
6(32)2011.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Palacín M, Alvarez V, Martín M, Díaz M,
Corao AI, Alonso B, Díaz-Molina B, Lozano I, Avanzas P, Morís C, et
al: Mitochondrial DNA and TFAM gene variation in early-onset
myocardial infarction: Evidence for an association to haplogroup H.
Mitochondrion. 11:176–181. 2011.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Zhang Q, Yu J-T, Wang P, Chen W, Wu Z-C,
Jiang H and Tan L: Mitochondrial transcription factor A (TFAM)
polymorphisms and risk of late-onset Alzheimer's disease in Han
Chinese. Brain Res. 1368:355–360. 2011.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Günther C, von Hadeln K, Müller-Thomsen T,
Alberici A, Binetti G, Hock C, Nitsch RM, Stoppe G, Reiss J, Gal A,
et al: Possible association of mitochondrial transcription factor A
(TFAM) genotype with sporadic Alzheimer disease. Neurosci Lett.
369:219–223. 2004.PubMed/NCBI View Article : Google Scholar
|
